Redeye returns following Elicera's Q4 report and recent news in the company. We largely reiterate our stance, but make some additional changes to our valuation, leading to a slight increase in our base case.
ANNONS
Redeye returns following Elicera's Q4 report and recent news in the company. We largely reiterate our stance, but make some additional changes to our valuation, leading to a slight increase in our base case.